Immunosuppressive therapy and COVID-19 infection in patients with NMOSD
Description
INTRODUCTION: To evaluate whether treated with immunosuppressants in neuromyelitis optica spectrum disorder (NMOSD) shows an effect on the severity and outcomes of COVID-19 Omicron variant.
